<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <?epub December-1-2011?>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">3245036</article-id>
    <article-id pub-id-type="pmid">22135288</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkr1142</article-id>
    <article-id pub-id-type="publisher-id">gkr1142</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Dr.VIS: a database of human disease-related viral integration sites</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Xin</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Qi</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cai</surname>
          <given-names>Qingqing</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Yanyun</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xu</surname>
          <given-names>Congjian</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Yixue</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Zuofeng</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>3</sup>
        </xref>
        <xref ref-type="corresp" rid="gkr1142-COR1">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Xiaoyan</given-names>
        </name>
        <xref ref-type="aff" rid="gkr1142-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="corresp" rid="gkr1142-COR1">*</xref>
      </contrib>
    </contrib-group>
    <aff id="gkr1142-AFF1"><sup>1</sup>School of Life Sciences and Technology, Tongji University, 1239 Siping Road, Shanghai, <sup>2</sup>Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011 and <sup>3</sup>Shanghai Center for Bioinformation Technology, 100 Qinzhou Road, Shanghai, China</aff>
    <author-notes>
      <corresp id="gkr1142-COR1">*To whom correspondence should be addressed. Tel: <phone>+86 021 65980233</phone>; Fax: <fax>+86 021 65981041</fax>; Email: <email>xyzhang@tongji.edu.cn</email></corresp>
      <corresp id="gkr1142-COR2">Correspondence may also be addressed to Zuofeng Li. Tel: <phone>+86 021 54065268</phone>; Fax: <fax>+86 021 54065057</fax>; Email: <email>lizuofeng@gmail.com</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <month>1</month>
      <year>2012</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>30</day>
      <month>11</month>
      <year>2011</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>30</day>
      <month>11</month>
      <year>2011</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>40</volume>
    <issue>Database issue</issue>
    <issue-title>Database issue</issue-title>
    <fpage>D1041</fpage>
    <lpage>D1046</lpage>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>10</month>
        <year>2011</year>
      </date>
      <date date-type="rev-recd">
        <day>9</day>
        <month>11</month>
        <year>2011</year>
      </date>
      <date date-type="accepted">
        <day>9</day>
        <month>11</month>
        <year>2011</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2011. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2011</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
        <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Viral integration plays an important role in the development of malignant diseases. Viruses differ in preferred integration site and flanking sequence. Viral integration sites (VIS) have been found next to oncogenes and common fragile sites. Understanding the typical DNA features near VIS is useful for the identification of potential oncogenes, prediction of malignant disease development and assessing the probability of malignant transformation in gene therapy. Therefore, we have built a database of human disease-related VIS (Dr.VIS, <ext-link ext-link-type="uri" xlink:href="http://www.scbit.org/dbmi/drvis">http://www.scbit.org/dbmi/drvis</ext-link>) to collect and maintain human disease-related VIS data, including characteristics of the malignant disease, chromosome region, genomic position and viral–host junction sequence. The current build of Dr.VIS covers about 600 natural VIS of 5 oncogenic viruses representing 11 diseases. Among them, about 200 VIS have viral–host junction sequence.</p>
    </abstract>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>INTRODUCTION</title>
    <p>The contribution of infectious agents to the development of serious human diseases, especially tumors, is increasingly understood (<xref rid="gkr1142-B1" ref-type="bibr">1</xref>). It is estimated that viral infections contribute to 15–20% of all human cancers (<xref rid="gkr1142-B2" ref-type="bibr">2</xref>). Research has revealed that integration of viral genomes into human chromosomes is necessary for most viral induction of tumor development, which can activate or inactivate host genes by means of provirus insertion (<xref rid="gkr1142-B2" ref-type="bibr">2</xref>,<xref rid="gkr1142-B3" ref-type="bibr">3</xref>). This holds not only for retroviruses such as human T-cell leukemia virus (<xref rid="gkr1142-B4" ref-type="bibr">4</xref>), but also for a number of non-retroviruses such as human papillomavirus (<xref rid="gkr1142-B5" ref-type="bibr">5</xref>) and hepatitis B virus (<xref rid="gkr1142-B2" ref-type="bibr">2</xref>,<xref rid="gkr1142-B6" ref-type="bibr">6</xref>). Finally, integration events can cause rearrangements of viral and host sequences (<xref rid="gkr1142-B7" ref-type="bibr">7</xref>), expression of fused transcripts, deletions of chromosomal sequences and transpositions of viral sequences from one chromosome to another (<xref rid="gkr1142-B8" ref-type="bibr">8–10</xref>). Viral integration is site-specific in many cases (<xref rid="gkr1142-B11" ref-type="bibr">11</xref>). Moreover, viruses differ in their preferred insertion site (<xref rid="gkr1142-B12" ref-type="bibr">12</xref>). Viral integration sites (VIS) have become a key to associating viral infection and human malignant disease.</p>
    <p>Up to date, at least seven viruses have been compellingly associated with human malignant diseases, including:
<list list-type="order"><list-item><p>HTLV-1 (adult T-cell leukemia and tropical spastic paraparesis) (<xref rid="gkr1142-B13" ref-type="bibr">13</xref>);</p></list-item><list-item><p>HPV (cervical cancer, head and neck cancer and anogenital cancer) (<xref rid="gkr1142-B14" ref-type="bibr">14</xref>,<xref rid="gkr1142-B15" ref-type="bibr">15</xref>);</p></list-item><list-item><p>HHV-8 (Kaposi's sarcoma) (<xref rid="gkr1142-B16" ref-type="bibr">16</xref>);</p></list-item><list-item><p>EBV (Burkitt's lymphoma) (<xref rid="gkr1142-B17" ref-type="bibr">17</xref>);</p></list-item><list-item><p>HBV (hepatocellular carcinoma) (<xref rid="gkr1142-B18" ref-type="bibr">18</xref>);</p></list-item><list-item><p>MCV, Merkel cell polyomavirus (Merkel cell carcinoma) (<xref rid="gkr1142-B19" ref-type="bibr">19</xref>); and</p></list-item><list-item><p>HIV (AIDS and B-cell lymphoma) (<xref rid="gkr1142-B1" ref-type="bibr">1</xref>).</p></list-item></list></p>
    <p>There are many viruses that are potentially associated with human malignant diseases such as Simian virus 40 (brain cancer, bone cancer and mesothelioma), BK virus (prostate cancer) and so on (<xref rid="gkr1142-B1" ref-type="bibr">1–3</xref>). Some are still under study, such as xenotropic murine leukemia virus-related virus whose relationship with prostate cancer is still controversial (<xref rid="gkr1142-B20" ref-type="bibr">20–22</xref>). Most of those viruses have a significant integration step in viral infection and disease development.</p>
    <p>Viral integration can activate gene expression to cause malignant disease if the VIS is close to an oncogene. This process known as insertional mutagenesis (<xref rid="gkr1142-B23" ref-type="bibr">23</xref>), has allowed identification of potential cellular oncogenes through mapping of retroviral integration sites (<xref rid="gkr1142-B23" ref-type="bibr">23</xref>,<xref rid="gkr1142-B24" ref-type="bibr">24</xref>). This work has also led to the development of a database of cancer-associated genes (<xref rid="gkr1142-B23" ref-type="bibr">23</xref>,<xref rid="gkr1142-B25" ref-type="bibr">25</xref>).</p>
    <p>Gene therapy holds promise for curing many malignant diseases. However, current gene therapy methods have limited control over where a therapeutic virus inserts into the human genome. It was reported that several patients developed T-cell leukemia during treatment of X-linked severe combined immunodeficiency (SCID-X1), because of viral integration near the proto-oncogenes LMO2, BMI1 and CCND2 (<xref rid="gkr1142-B23" ref-type="bibr">23</xref>,<xref rid="gkr1142-B26" ref-type="bibr">26</xref>).</p>
    <p>Therefore, understanding the genes and DNA features near disease-related VIS will abet the identification of potential oncogenes, prediction of malignant disease development and assessment of the probability of malignant transformation in gene therapy. However, numerous identified VIS are still widely scattered in published papers. In this study, we developed a database of human disease-related VIS (Dr.VIS) to collect and maintain those data from the literature (PubMed) and public databases (GenBank) (<xref rid="gkr1142-B27" ref-type="bibr">27</xref>). Furthermore, each VIS is linked to the UCSC Genome Browser (<xref rid="gkr1142-B28" ref-type="bibr">28</xref>) and Ensembl Genome Browser (<xref rid="gkr1142-B29" ref-type="bibr">29</xref>) for more detailed viewing of genomic traits.</p>
  </sec>
  <sec sec-type="materials|methods">
    <title>MATERIALS AND METHODS</title>
    <sec>
      <title>Data model of VIS and clusters</title>
      <p>The following characteristics are listed for each human disease-related VIS: virus name, chromosome region, locus, genomic position, viral–host junction sequence and corresponding human disease. The chromosome region is denoted as cytogenetic band. The locus must have been approved by HGNC (<xref rid="gkr1142-B30" ref-type="bibr">30</xref>) and can be a microRNA or an interrupted gene with specific coordinates of subcomponents (exons or introns). Genomic position is the position of the insertion point in the genome as represented in the Human Genome Assembly 2009 (hg19) (<xref rid="gkr1142-B31" ref-type="bibr">31</xref>). Viral–host junction sequence is always recorded as ‘human genome–viral genome–human genome’.</p>
      <p>In Dr.VIS, VIS representing the same virus name, chromosome region and human disease, are clustered to generate a unique data entry called a viral integration cluster (or VIS cluster) for convenient data organization. Genomic traits of a VIS cluster include common fragile site (<xref rid="gkr1142-B32" ref-type="bibr">32</xref>), microRNA, gene distribution and son on. More detailed traits are crosslinked to HGNC (<xref rid="gkr1142-B30" ref-type="bibr">30</xref>), UCSC (<xref rid="gkr1142-B33" ref-type="bibr">33</xref>) and Ensembl (<xref rid="gkr1142-B29" ref-type="bibr">29</xref>), through their chromosome coordinates. Furthermore, each VIS cluster is assigned a confidence code (<xref ref-type="table" rid="gkr1142-T1">Table 1</xref>) to indicate its frequency.
<table-wrap id="gkr1142-T1" position="float"><label>Table 1.</label><caption><p>Confidence codes</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Code</th><th rowspan="1" colspan="1">Description</th><th rowspan="1" colspan="1">Integration sites count</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">WK</td><td rowspan="1" colspan="1">Well known</td><td rowspan="1" colspan="1"><italic>f</italic> ≥ 5</td></tr><tr><td rowspan="1" colspan="1">SS</td><td rowspan="1" colspan="1">Strongly supported</td><td rowspan="1" colspan="1">1 &lt; <italic>f</italic> &lt; 5</td></tr><tr><td rowspan="1" colspan="1">SO</td><td rowspan="1" colspan="1">Single observation</td><td rowspan="1" colspan="1"><italic>f</italic> = 1</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec>
      <title>Collection of VIS associated with human diseases</title>
      <p>VIS related to human disease were collected from PubMed and GenBank (<xref ref-type="fig" rid="gkr1142-F1">Figure 1</xref>). All VIS deposited in Dr.VIS are sequenced or detected from natural samples of patients. A Perl script extracted viral–host junction sequences from GenBank by matching keywords (i.e. integration site) and annotation of both host and virus (i.e. Homo sapiens and a virus) as regular expressions. The script extracted PMIDs from the original literature reporting junction sequences, for subsequent manual retrieval and processing curation from PubMed.
<fig id="gkr1142-F1" position="float"><label>Figure 1.</label><caption><p>Work flow of data collection and re-mapping.</p></caption><graphic xlink:href="gkr1142f1"/></fig></p>
      <p>Papers reporting disease-related viral integration into the human genome were collected from PubMed in two ways, by script as described immediately above, and by manual search of the keywords virus, integration site, cancer, tumor, malignancy and disease. About 200 initially selected papers were obtained and filtered for relevance; curators read nearly 80 finally selected papers in full to extract the VIS characteristics required in the data model. In some cases, exact junctions were transcribed from illustrations in the papers. Sequences denoted with accession numbers are downloaded directly from GenBank.</p>
    </sec>
    <sec>
      <title>Re-mapping of VIS</title>
      <p>Three fields of a VIS (genomic position, chromosome region and locus) are updated by re-mapping according to the viral–host junction sequence obtained (<xref ref-type="fig" rid="gkr1142-F1">Figure 1</xref>).</p>
      <sec>
        <title>Mapping of genomic position</title>
        <p>The genomic position of a VIS in the Human Genome Assembly 2009 (hg19) (<xref rid="gkr1142-B31" ref-type="bibr">31</xref>) is identified using BLAT from UCSC (<xref rid="gkr1142-B33" ref-type="bibr">33</xref>), provided that the identity of the BLAT result exceeds 80%. When there are two or more positive alignments, a manual check helps to choose the correct one.</p>
      </sec>
      <sec>
        <title>Mapping of locus</title>
        <p>The locus of integration is always interrupted, and potentially inactivated, by viral insertion. Loci were identified using the Genes and Gene Tracks Table from UCSC (<xref rid="gkr1142-B34" ref-type="bibr">34</xref>), and VIS were mapped to the gene component (exon, intron, 3′-untranslated region, promoter) on the basis of BLAT hit. All recognized loci were required to have been approved by the HGNC (<xref rid="gkr1142-B30" ref-type="bibr">30</xref>).</p>
      </sec>
      <sec>
        <title>Mapping of chromosome region</title>
        <p>The chromosome region (cytogenetic band) was subsequently calculated based on the insertion site's genomic position and the Chromosome Band Table from UCSC (<xref rid="gkr1142-B34" ref-type="bibr">34</xref>).</p>
      </sec>
    </sec>
    <sec>
      <title>Clustering of VIS</title>
      <p>As described in the data model, VIS are conditionally clustered as a unique data entry termed viral integration cluster (VIS cluster). A confidence code is assigned to each VIS cluster indicating its frequency, according to the number of insertion sites that it contains (<xref ref-type="table" rid="gkr1142-T1">Table 1</xref>). Statistics of integration clusters compellingly associated with human malignant disease are illustrated for the current build in <xref ref-type="fig" rid="gkr1142-F2">Figure 2</xref>.
<fig id="gkr1142-F2" position="float"><label>Figure 2.</label><caption><p>Distribution of VIS clusters associated with human malignant diseases. (<bold>A</bold>) Frequency of VIS clusters by virus type, (<bold>B</bold>) frequency of VIS clusters versus chromosome.</p></caption><graphic xlink:href="gkr1142f2"/></fig></p>
    </sec>
    <sec>
      <title>Web interfaces</title>
      <sec>
        <title>Data browser</title>
        <p>The data browser presents a catalog of links to chromosome, virus and disease. Currently, there are 24 chromosomes, 12 viruses and 12 diseases, which can be browsed for VIS.</p>
      </sec>
      <sec>
        <title>Data search</title>
        <p>Three search engines (keywords, position and the jQuery search engine) are implemented in the data interface. Users can search Dr.VIS with keywords of disease, virus, chromosome region, and so on, using the keyword search engine. VIS clusters can also be selected on the basis of genomic position or chromosome region (cytogenetic band). Users can filter the search result through the jQuery search engine, which is embed in the table list and is powered by jQuery.</p>
      </sec>
      <sec>
        <title>Data visualization</title>
        <p>For each VIS cluster, Dr.VIS provides an interface (<xref ref-type="fig" rid="gkr1142-F3">Figure 3</xref>) with details and links to the UCSC Genome Browser and the Ensembl Genome Browser. The graphic view (<xref ref-type="fig" rid="gkr1142-F4">Figure 4</xref>) summarizes the distribution of VIS clusters over any human chromosome. Any or all of the viruses can be selected for display.
<fig id="gkr1142-F3" position="float"><label>Figure 3.</label><caption><p>Screenshot of the VIS details interface.</p></caption><graphic xlink:href="gkr1142f3"/></fig>
<fig id="gkr1142-F4" position="float"><label>Figure 4.</label><caption><p>Screenshot of the graphic view of VIS located in human chromosome 1.</p></caption><graphic xlink:href="gkr1142f4"/></fig></p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="discussion">
    <title>DISCUSSION</title>
    <p>VIS associated with malignant disease were always detected in samples from patients. Many useful approaches have been applied or newly developed to identify VIS such as fluorescence in situ hybridization (FISH), linear amplification mediated PCR (LAM-PCR) (<xref rid="gkr1142-B35" ref-type="bibr">35</xref>), amplification of papillomavirus oncogene transcripts assay (APOT), detection of integrated papilloma sequences PCR (DIPS-PCR) and next-generation sequencing (<xref rid="gkr1142-B36" ref-type="bibr">36–38</xref>). In addition to VIS, directly detected in naturally infected samples, many integration sites have been indentified in artificial experiments or in silico (<xref rid="gkr1142-B39" ref-type="bibr">39</xref>), as with SeqMap (<xref rid="gkr1142-B23" ref-type="bibr">23</xref>). Dr.VIS was developed as a comprehensive database of VIS associated with human malignant diseases. Dr.VIS is intended to facilitate biomedical applications or systematic researches into molecular causation and anomalies. The current build focuses on, oncogenic viruses demonstrably associated with human cancers. Viruses potentially resulting in anomalies are also of great interest. Updates of Dr.VIS will be continuously supported, since causative viruses continue to be identified and the number of documented VIS is rapidly increasing.</p>
  </sec>
  <sec>
    <title>FUNDING</title>
    <p>Funding for open access charge: <funding-source>State Key Basic Research Program</funding-source>
<award-id>(973) (2011CB910204)</award-id>; <funding-source>National Natural Science Foundation of China</funding-source>
<award-id>(81101955)</award-id>; <funding-source>Major State Basic Research Development Program</funding-source> (<award-id>2010CB945501</award-id>); the <funding-source>863 Hi-Tech Program of China</funding-source> (<award-id>2009AA02Z308</award-id>); <funding-source>National Key Technology R&amp;D Program in the 11th Five Year Plan of China</funding-source> (<award-id>2008BAI64B01</award-id>) and <funding-source>Major State Basic Research Development Program of China</funding-source> (<award-id>2010CB529200</award-id>).</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
</body>
<back>
  <ack>
    <title>ACKNOWLEDGEMENTS</title>
    <p>The authors thank Dr Charles F. Crane, USDA-ARS, West Lafayette, IN, USA for the great support during manuscript preparation. The authors are grateful to Ms Xinyi Liu from Shanghai Jiao Tong University for comments on the earlier versions of the manuscript. The authors also thank Dr Michael Galperin for the helpful suggestions.</p>
  </ack>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="gkr1142-B1">
      <label>1</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Talbot</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Crawford</surname>
            <given-names>DH</given-names>
          </name>
        </person-group>
        <article-title>Viruses and tumours – an update</article-title>
        <source>Eur. J. Cancer</source>
        <year>2004</year>
        <volume>40</volume>
        <fpage>1998</fpage>
        <lpage>2005</lpage>
        <pub-id pub-id-type="pmid">15315810</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morissette</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Flamand</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Herpesviruses and chromosomal integration</article-title>
        <source>J. Virol.</source>
        <year>2010</year>
        <volume>84</volume>
        <fpage>12100</fpage>
        <lpage>12109</lpage>
        <pub-id pub-id-type="pmid">20844040</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McLaughlin-Drubin</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Munger</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Viruses associated with human cancer</article-title>
        <source>Biochim. Biophys. Acta</source>
        <year>2008</year>
        <volume>1782</volume>
        <fpage>127</fpage>
        <lpage>150</lpage>
        <pub-id pub-id-type="pmid">18201576</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giam</surname>
            <given-names>CZ</given-names>
          </name>
          <name>
            <surname>Jeang</surname>
            <given-names>KT</given-names>
          </name>
        </person-group>
        <article-title>HTLV-1 Tax and adult T-Cell leukemia</article-title>
        <source>Front. Biosci.</source>
        <year>2007</year>
        <volume>12</volume>
        <fpage>1496</fpage>
        <lpage>1507</lpage>
        <pub-id pub-id-type="pmid">17127397</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>zur Hausen</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Papillomavirus infections–a major cause of human cancers</article-title>
        <source>Biochim. Biophys. Acta</source>
        <year>1996</year>
        <volume>1288</volume>
        <fpage>F55</fpage>
        <lpage>F78</lpage>
        <pub-id pub-id-type="pmid">8876633</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kremsdorf</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Soussan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Paterlini-Brechot</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Brechot</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis</article-title>
        <source>Oncogene</source>
        <year>2006</year>
        <volume>25</volume>
        <fpage>3823</fpage>
        <lpage>3833</lpage>
        <pub-id pub-id-type="pmid">16799624</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brechot</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms</article-title>
        <source>Gastroenterology</source>
        <year>2004</year>
        <volume>127</volume>
        <fpage>S56</fpage>
        <lpage>S61</lpage>
        <pub-id pub-id-type="pmid">15508104</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dandri</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Burda</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Bürkle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zuckerman</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Will</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Rogler</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Greten</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Petersen</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation</article-title>
        <source>Hepatology</source>
        <year>2002</year>
        <volume>35</volume>
        <fpage>217</fpage>
        <lpage>223</lpage>
        <pub-id pub-id-type="pmid">11786979</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>HP</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Dandri</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rogler</surname>
            <given-names>CE</given-names>
          </name>
        </person-group>
        <article-title>Antisense downregulation of N-myc1 in woodchuck hepatoma cells reverses the malignant phenotype</article-title>
        <source>J. Virol.</source>
        <year>1998</year>
        <volume>72</volume>
        <fpage>2192</fpage>
        <lpage>2198</lpage>
        <pub-id pub-id-type="pmid">9499076</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Klimov</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Vinokourova</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Moisjak</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rakhmanaliev</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kobseva</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Laimins</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kisseljov</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sulimova</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Human papilloma viruses and cervical tumours: mapping of integration sites and analysis of adjacent cellular sequences</article-title>
        <source>BMC Cancer</source>
        <year>2002</year>
        <volume>2</volume>
        <fpage>24</fpage>
        <pub-id pub-id-type="pmid">12377107</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kotin</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Siniscalco</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Samulski</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>XD</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Laughlin</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>McLaughlin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Muzyczka</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rocchi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Berns</surname>
            <given-names>KI</given-names>
          </name>
        </person-group>
        <article-title>Site-specific integration by adeno-associated virus</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>1990</year>
        <volume>87</volume>
        <fpage>2211</fpage>
        <lpage>2215</lpage>
        <pub-id pub-id-type="pmid">2156265</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lewinski</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Yamashita</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Emerman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ciuffi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Crawford</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Shinn</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Leipzig</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hannenhalli</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Retroviral DNA integration: viral and cellular determinants of target-site selection</article-title>
        <source>PLoS Pathog.</source>
        <year>2006</year>
        <volume>2</volume>
        <fpage>e60</fpage>
        <pub-id pub-id-type="pmid">16789841</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Poiesz</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Ruscetti</surname>
            <given-names>FW</given-names>
          </name>
          <name>
            <surname>Gazdar</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Bunn</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Minna</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Gallo</surname>
            <given-names>RC</given-names>
          </name>
        </person-group>
        <article-title>Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>1980</year>
        <volume>77</volume>
        <fpage>7415</fpage>
        <lpage>7419</lpage>
        <pub-id pub-id-type="pmid">6261256</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dürst</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gissmann</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ikenberg</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>zur Hausen</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>1983</year>
        <volume>80</volume>
        <fpage>3812</fpage>
        <lpage>3815</lpage>
        <pub-id pub-id-type="pmid">6304740</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boshart</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gissmann</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ikenberg</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kleinheinz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scheurlen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>zur Hausen</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer</article-title>
        <source>EMBO J.</source>
        <year>1984</year>
        <volume>3</volume>
        <fpage>1151</fpage>
        <lpage>1157</lpage>
        <pub-id pub-id-type="pmid">6329740</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cesarman</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Pessin</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Culpepper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Knowles</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>PS</given-names>
          </name>
        </person-group>
        <article-title>Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma</article-title>
        <source>Science</source>
        <year>1994</year>
        <volume>266</volume>
        <fpage>1865</fpage>
        <lpage>1869</lpage>
        <pub-id pub-id-type="pmid">7997879</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Epstein</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Achong</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Barr</surname>
            <given-names>YM</given-names>
          </name>
        </person-group>
        <article-title>Virus particles in cultured lymphoblasts from Burkitt's lymphoma</article-title>
        <source>Lancet</source>
        <year>1964</year>
        <volume>1</volume>
        <fpage>702</fpage>
        <lpage>703</lpage>
        <pub-id pub-id-type="pmid">14107961</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dane</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Briggs</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Virus-like particles in serum of patients with Australia-antigen-associated hepatitis</article-title>
        <source>Lancet</source>
        <year>1970</year>
        <volume>1</volume>
        <fpage>695</fpage>
        <lpage>698</lpage>
        <pub-id pub-id-type="pmid">4190997</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Laude</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Jonchère</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Maubec</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Carlotti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Marinho</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Couturaud</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Peter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sastre-Garau</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Avril</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Dupin</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma</article-title>
        <source>PLoS Pathog.</source>
        <year>2010</year>
        <volume>6</volume>
        <fpage>e1001076</fpage>
        <pub-id pub-id-type="pmid">20865165</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Boren</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Das Gupta</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gaughan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Silverman</surname>
            <given-names>RH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer</article-title>
        <source>J. Virol.</source>
        <year>2008</year>
        <volume>82</volume>
        <fpage>9964</fpage>
        <lpage>9977</lpage>
        <pub-id pub-id-type="pmid">18684813</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Switzer</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Heneine</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>No association of xenotropic murine leukemia virus-related viruses with prostate cancer</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e19065</fpage>
        <pub-id pub-id-type="pmid">21573232</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sakuma</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hué</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Squillace</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Tonne</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Blackburn</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Ohmine</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Thatava</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Towers</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Ikeda</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>No evidence of XMRV in prostate cancer cohorts in the Midwestern United States</article-title>
        <source>Retrovirology</source>
        <year>2011</year>
        <volume>8</volume>
        <fpage>23</fpage>
        <pub-id pub-id-type="pmid">21447170</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B23">
      <label>23</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hawkins</surname>
            <given-names>TB</given-names>
          </name>
          <name>
            <surname>Dantzer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Peters</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dinauer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mockaitis</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mooney</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cornetta</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Identifying viral integration sites using SeqMap 2.0</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <fpage>720</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="pmid">21245052</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B24">
      <label>24</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Buchberg</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Bedigian</surname>
            <given-names>HG</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Copeland</surname>
            <given-names>NG</given-names>
          </name>
        </person-group>
        <article-title>Evi-2, a common integration site involved in murine myeloid leukemogenesis</article-title>
        <source>Mol. Cell. Biol.</source>
        <year>1990</year>
        <volume>10</volume>
        <fpage>4658</fpage>
        <lpage>4666</lpage>
        <pub-id pub-id-type="pmid">2167436</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B25">
      <label>25</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Akagi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Stephens</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Copeland</surname>
            <given-names>NG</given-names>
          </name>
        </person-group>
        <article-title>RTCGD: retroviral tagged cancer gene database</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>D523</fpage>
        <lpage>D527</lpage>
        <pub-id pub-id-type="pmid">14681473</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B26">
      <label>26</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hacein-Bey-Abina</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Von Kalle</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schmidt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>McCormack</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Wulffraat</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Leboulch</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Osborne</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Pawliuk</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Morillon</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1</article-title>
        <source>Science</source>
        <year>2003</year>
        <volume>302</volume>
        <fpage>415</fpage>
        <lpage>419</lpage>
        <pub-id pub-id-type="pmid">14564000</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B27">
      <label>27</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benson</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Karsch-Mizrachi</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lipman</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Ostell</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sayers</surname>
            <given-names>EW</given-names>
          </name>
        </person-group>
        <article-title>GenBank</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>D32</fpage>
        <lpage>D37</lpage>
        <pub-id pub-id-type="pmid">21071399</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B28">
      <label>28</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sanborn</surname>
            <given-names>JZ</given-names>
          </name>
          <name>
            <surname>Benz</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Craft</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Szeto</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kober</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vaske</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Goldman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Kuhn</surname>
            <given-names>RM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The UCSC Cancer Genomics Browser: update 2011</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>D951</fpage>
        <lpage>D959</lpage>
        <pub-id pub-id-type="pmid">21059681</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B29">
      <label>29</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Flicek</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Amode</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Barrell</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Beal</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Brent</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Clapham</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Coates</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fairley</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fitzgerald</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ensembl 2011</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>D800</fpage>
        <lpage>D806</lpage>
        <pub-id pub-id-type="pmid">21045057</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B30">
      <label>30</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seal</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Lush</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Wright</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Bruford</surname>
            <given-names>EA</given-names>
          </name>
        </person-group>
        <article-title>genenames.org: the HGNC resources in 2011</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>D514</fpage>
        <lpage>D519</lpage>
        <pub-id pub-id-type="pmid">20929869</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B31">
      <label>31</label>
      <element-citation publication-type="journal">
        <collab>The Genome Sequencing Consortium</collab>
        <article-title>Initial sequencing and analysis of the human genome</article-title>
        <source>Nature</source>
        <year>2001</year>
        <volume>409</volume>
        <fpage>860</fpage>
        <lpage>921</lpage>
        <pub-id pub-id-type="pmid">11237011</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B32">
      <label>32</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thorland</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Gostout</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>DI</given-names>
          </name>
        </person-group>
        <article-title>Common fragile sites are preferential targets for HPV16 integrations in cervical tumors</article-title>
        <source>Oncogene</source>
        <year>2003</year>
        <volume>22</volume>
        <fpage>1225</fpage>
        <lpage>1237</lpage>
        <pub-id pub-id-type="pmid">12606949</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B33">
      <label>33</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kent</surname>
            <given-names>WJ</given-names>
          </name>
        </person-group>
        <article-title>BLAT–the BLAST-like alignment tool</article-title>
        <source>Genome Res.</source>
        <year>2002</year>
        <volume>12</volume>
        <fpage>656</fpage>
        <lpage>664</lpage>
        <pub-id pub-id-type="pmid">11932250</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B34">
      <label>34</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karolchik</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hinrichs</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Furey</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Roskin</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Sugnet</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Haussler</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kent</surname>
            <given-names>WJ</given-names>
          </name>
        </person-group>
        <article-title>The UCSC Table Browser data retrieval tool</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2002</year>
        <volume>32</volume>
        <fpage>D493</fpage>
        <lpage>D496</lpage>
        <pub-id pub-id-type="pmid">14681465</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B35">
      <label>35</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hüser</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gogol-Doring</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lutter</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Weger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hammer</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Cathomen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Reinert</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Heilbronn</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome</article-title>
        <source>PLoS Pathog.</source>
        <year>2010</year>
        <volume>6</volume>
        <fpage>e1000985</fpage>
        <pub-id pub-id-type="pmid">20628575</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B36">
      <label>36</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schuster</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Next-generation sequencing transforms today’s biology</article-title>
        <source>Nat. Methods</source>
        <year>2008</year>
        <volume>5</volume>
        <fpage>16</fpage>
        <lpage>18</lpage>
        <pub-id pub-id-type="pmid">18165802</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B37">
      <label>37</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mardis</surname>
            <given-names>ER</given-names>
          </name>
        </person-group>
        <article-title>The impact of next-generation sequencing technology on genetics</article-title>
        <source>Trends Genet.</source>
        <year>2008</year>
        <volume>24</volume>
        <fpage>133</fpage>
        <lpage>141</lpage>
        <pub-id pub-id-type="pmid">18262675</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B38">
      <label>38</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cronin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>JS</given-names>
          </name>
        </person-group>
        <article-title>Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology</article-title>
        <source>Biomark. Med.</source>
        <year>2011</year>
        <volume>5</volume>
        <fpage>293</fpage>
        <lpage>305</lpage>
        <pub-id pub-id-type="pmid">21657839</pub-id>
      </element-citation>
    </ref>
    <ref id="gkr1142-B39">
      <label>39</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>DRUMS: a human disease related unique gene mutation search engine</article-title>
        <source>Hum. Mutat.</source>
        <year>2011</year>
        <volume>32</volume>
        <fpage>E2259</fpage>
        <lpage>E2265</lpage>
        <pub-id pub-id-type="pmid">21913285</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
